thiobarbituric-acid and Diabetic-Angiopathies

thiobarbituric-acid has been researched along with Diabetic-Angiopathies* in 1 studies

Other Studies

1 other study(ies) available for thiobarbituric-acid and Diabetic-Angiopathies

ArticleYear
Oxidative stress in diabetic macrovascular disease: does homocysteine play a role?
    Southern medical journal, 1997, Volume: 90, Issue:9

    Non-insulin-dependent diabetes mellitus (NIDDM) and hyperhomocysteinemia are both associated with increased lipid peroxidation (oxidative stress). This may contribute to the accelerated vascular disease associated with these conditions. It is not known whether the coexistence of elevated homocysteine levels will stimulate oxidative stress further than that caused by diabetes alone.. Plasma concentrations of thiobarbituric acid reactive substances (TBARS), an index of lipid peroxidation, were measured in patients with NIDDM who had previously had a methionine load test; some of the patients had hyperhomocysteinemia.. Plasma TBARS concentrations were elevated in diabetics with vascular disease. The additional presence of hyperhomocysteinemia was not associated with a further increase in plasma TBARS concentrations.. Lipid peroxidation is increased in patients with diabetes mellitus and macrovascular disease and is not further elevated by the coexistence of elevated homocysteine levels. It is possible that diabetes maximally stimulates oxidative stress and any further acceleration of vascular disease in patients who have coexistent hyperhomocysteinemia is mediated through mechanisms other than lipid peroxidation.

    Topics: Adult; Analysis of Variance; Brain Ischemia; Carotid Artery Diseases; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Free Radicals; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Lipid Peroxidation; Male; Methionine; Middle Aged; Oxidative Stress; Peripheral Vascular Diseases; Sulfonylurea Compounds; Thiobarbiturates

1997